Business Wire

Hanshow Strengthens Global Ecosystem by Partnering with Glintt Life and shopreme to Drive Smart Retail Digitalization

24.9.2025 08:06:00 CEST | Business Wire | Press Release

Share

Hanshow, a global leader in digital retail solutions, is deepening its global ecosystem through strategic collaborations that connect local market expertise with advanced retail technology. The latest partnerships bring together Glintt—a technology and distribution powerhouse in the Iberian pharmacy sector—and shopreme, a leading provider of self-checkout and smart-cart solutions. Rather than parallel initiatives, these relationships plug into one architecture that links digital pricing, in-store media, checkout innovation, and sector-specific workflows to accelerate smart retail digitalization at scale.

Through its companies Pulso and Consoft, responsible for the pharmacy management software Nixfarma and Farmatic, Glintt Life connects more than 12,000 pharmacies across Spain with platforms that support prescriptions, logistics, and services. This solid footprint, combined with Glintt Life’s track record in healthcare digitalization, positions the brand as a trusted partner to bring Hanshow’s retail innovations into the pharmacy channel. “Our partnership with Hanshow enables us to bring intelligent retail tools into pharmacies, transforming how healthcare providers serve patients with efficiency and personalization,” said Luis Esgueva, Executive at Glintt Global and responsible for the Glintt Life pharmacy business in Spain.

shopreme's unified self-checkout ecosystem, deployed in over 2,000 stores worldwide, complements Hanshow's smart cart tablets and in-store media with its snap cart software. For retailers, the result is retrofit-ready, scalable, and GDPR-compliant—reducing shrinkage, enhancing the shopping journey, and opening new retail-media monetization opportunities. “By joining forces with Hanshow, we’re creating a future-ready checkout model that blends customer convenience with operational efficiency and new in-store media capabilities,” said Nico Müller, CCO at shopreme.

Hanshow’s ecosystem approach extends across regions and categories through long-standing relationships with local leaders and specialized innovators. In Southern Europe, ICS Karafyllis S.A. supports fiscal solutions and POS services across Greece and Cyprus; throughout Europe, Shop&Roll contributes shopping-transport, visual-merchandising, and POS equipment with award-winning sustainable designs; in the Middle East, Arab Mechanical Engineers enables retailers to adopt and scale digital in-store technologies. Together with Glintt and shopreme, these partners operate as connected nodes in a single network—localizing quickly, compounding value, and shortening time-to-impact for retailers worldwide.

“We are excited to advance this ecosystem alongside partners such as Glintt and shopreme in Europe, ICS Karafyllis S.A. in Greece and Cyprus, Shop&Roll across European markets, Arab Mechanical Engineers in the Middle East, and other regional innovators,” said Liangyan Li, Senior Vice President at Hanshow. “By uniting local reach with Hanshow’s digital capabilities—from ESL and in-store media to seamless checkout—we’re helping retailers lower costs, enhance efficiency, and accelerate sustainable, customer-focused transformation across the global marketplace.”

About Glintt

Glintt is a leading Iberian technology and services group, with a strong presence in the healthcare and pharmaceutical retail sector. In Spain, Glintt operates through Nixfarma, connecting hundreds of pharmacies and supporting the industry with digital tools, distribution, and operational excellence. For more information, please click here.

About shopreme

shopreme is a leading provider of self-checkout solutions, offering a comprehensive portfolio of innovative technologies to enhance the retail shopping experience. With solutions such as Scan & Go, SCO, AI-based Loss Prevention, and Smart Cart, shopreme is revolutionizing the way customers shop and pay in brick-and-mortar stores – in more than 2,000 stores worldwide. For more information, please click here.

About Hanshow

Hanshow is a global leader in developing and manufacturing electronic shelf labels and digital store solutions. The company offers customers a series of customized IoT touchpoints and digital store solutions that deliver customer-centric insights. Hanshow’s solutions have provided services to a vast number of stores in over 70 countries and regions, helping them streamline operations, optimize pricing strategies, and offer customers a more personalized experience. Learn more : www.hanshow.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20250923729516/en/

Contacts

info@hanshow.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye